Harry Lamble

Harry has extensive experience in the management of high growth businesses in the life sciences. He was previously co-founder and CEO of Sense Biodetection, who developed Veros, the world's first rapid instrument free molecular diagnostic test. Originally a molecular scientist, he holds a PhD from University of Bath and an MBA from Cranfield. His other previous affiliations include Oxford Biotherapeutics and Imperial College London.